Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation
LIMERICK, Ireland, Jan. 09, 2025 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading global therapeutics company (“the… Read More »Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation